Business Wire

CA-GENERATE-CAPITAL

31.1.2024 16:01:35 CET | Business Wire | Press release

Share
Leading Global Institutions Invest in a Clean Energy Future With Generate Capital

Today, Generate Capital (“Generate”), a leading sustainable infrastructure platform, announced the closing of its latest capital raise with $1.5 billion in new capital commitments from preeminent global institutional investors. The California State Teachers’ Retirement System (“CalSTRS”), the world’s largest educator-only pension fund, joined other new investors such as HESTA, as well as existing investors including QIC and AustralianSuper, in the financing. This new round brings the total capital raised by Generate since its inception in 2014 to over $10 billion.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240130298422/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

In partnership with project developers, technology companies, and investors, Generate has established a diverse portfolio of thousands of sustainable infrastructure projects around the world. (Photo: Business Wire)

Over the last decade, Generate has developed a creative and flexible platform dedicated entirely to accelerating the infrastructure transition – from building and financing infrastructure assets to incubating, building and financing leading infrastructure companies. The result is an integrated offering – a “one-stop shop” – for capital, innovators, customers, and communities committed to rebuilding the world. Since its founding, Generate has partnered with more than 50 project development and technology companies, dozens of investors and hundreds of communities to establish a diverse portfolio of thousands of sustainable infrastructure projects around the world.

As of September 2023, Generate helped produce over 320GWh of sustainable power and process more than 715Kt in organic waste. In addition to its project portfolio, Generate’s subsidiaries and portfolio companies are leading the infrastructure transition, bringing value to waste through Generate Upcycle, making the electric grid more reliable through esVolta, and expanding renewable power generation with Nexamp and Pine Gate Renewables. In 2023, Generate expanded its creative approach to accelerating the transition by entering joint ventures with Blue Bird Corporation to bring electric school buses to districts across the country and with McKinstry to accelerate energy efficiency with municipal customers. The flexibility and innovation of the platform combined with its record of success providing compelling returns to investors allowed for a successful fundraise in a more constrained capital markets environment.

“We're at an inflection point in the transition to a clean energy economy,” says Generate Capital CEO and co-founder Scott Jacobs. “While the window for action is getting smaller every day, we have the blueprints to build the critical infrastructure that will ensure a livable future. We need to invest trillions, not billions. Ten billion dollars is just a start. We are incredibly proud that our differentiated model integrating finance and operations, meshing innovation with scale, harnessing top talent, and being totally dedicated to this transition attracts the world’s best partners and continues to deliver for our investors and communities.”

CalSTRS' participation in this capital raise establishes a strategic partnership with Generate and deepens their ongoing investment in the platform.

“Our mission is to provide a secure retirement for California’s public educators and beneficiaries,” said Kirsty Jenkinson, CalSTRS' Director of Sustainable Investment and Stewardship Strategies. “Our strategic partnership with Generate Capital aligns with our mission to deliver superior financial returns for our portfolio while creating demonstrable positive outcomes for the environment and society.”

“Generate Capital has delivered strong returns for AustralianSuper members,” said AustralianSuper Global Head of Real Assets, Nik Kemp. “We look forward to Generate continuing to deliver great performance while also playing a pivotal role in the global clean infrastructure transition.”

Some of Generate’s key 2023 highlights include:

  • Over $2 billion invested in the energy transition, building more infrastructure assets, growing infrastructure companies, and financing leading players.
  • Viridis Initiative, a joint venture established with McKinstry, was launched to deliver turnkey energy-as-a-service (EaaS) solutions to municipalities, universities, schools, and hospitals.
  • Clean Bus Solutions, a joint venture established with the Blue Bird Corporation, was launched to meet the increasing demand for electric school buses and accelerate the adoption of clean transportation of students in North America.
  • Generate helped Hillsborough County Public Schools finance, install and maintain energy efficiency solutions across its facilities. This resulted in the district avoiding $13 million in annual utility costs, reduction in CO2 emissions by 45,000 metric tons, and improved air quality in 100% of the public schools as of July 2023.
  • Pine Gate Renewables, in which Generate has partnered with the founding team to invest and build the company, became the country’s third-largest solar developer.
  • esVolta, a Generate subsidiary, closed one of the energy storage industry’s first standalone storage tax equity investments, taking advantage of the Inflation Reduction Act with U.S. Bank to finance the completion of a 30MW/60MWh utility-scale energy storage project in California.
  • Ubiquity, in which Generate has partnered with the founding team to invest and build the company, is now both the largest and fastest growing open-access broadband network in the country.

About Generate Capital

Generate Capital, PBC is a leading sustainable investment and operating company driving the infrastructure transition. Generate builds, owns, operates and finances clean energy, transportation, water, waste, agriculture and digital infrastructure. Founded in 2014, Generate has partnered with over 50 technology and project developers and owns and operates more than 2,000 assets globally. Generate is a one-stop-shop offering pioneers of the infrastructure revolution tailored funding and support needed to get projects built. The company’s Infrastructure-as-a-Service model delivers affordable, reliable and sustainable resources to thousands of customers, companies, communities, school districts and universities. Together, we are rebuilding the world. For more information, please visit www.generatecapital.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240130298422/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye